Taysha Gene Therapies Inc. TSHA
$5.72
▲ +2.33% 24H
About
Taysha Gene Therapies Inc. is a biotechnology company specializing in the development of transformative gene therapy treatments for central nervous system (CNS) diseases. The company is at the forefront of employing advanced gene therapy techniques to address rare, debilitating neurological conditions that lack effecti…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees99
TickerTSHA
Statistics
Market Cap$1.64B
Revenue (TTM)$9.8M
Net Income-$109.0M
Net Margin-1115.3%
EPS$-0.34
P/E2.53
P/S219.63
P/B6.59
EV/EBITDA-10.90
ROE-97.3%
Dividend Yield—
Price$5.72
Data: Twelve Data · Revenue = mcap / P/S